India Says More Than Half Of Drug Maker Group Failed To File Pricing Data
This article was originally published in PharmAsia News
Fifty-five drugs face elimination from India's watchdog list of antibiotics, painkillers and other formulations set for price caps because their manufacturers failed to supply information as required.
You may also be interested in...
The UK government says it will begin a consultation on a future falsified medicines scheme for Great Britain within a year after the passage of new legislation on medicines and medical devices. Moves are also under way to ensure the smooth supply of medicines from GB to Cyprus, Ireland, Malta and Northern Ireland.
The sentences are the latest chapter in a long-running off-label marketing case.
The Israel-based, NASDAQ-listed biotech tells Scrip that if the oral SK2 selective inhibitor succeeds in a Phase II/III study, it would be "very comfortable" taking opaganib all the way to market on its own.